Epigenetic regulation in neurodegenerative diseases

A Berson, R Nativio, SL Berger, NM Bonini - Trends in neurosciences, 2018 - cell.com
Mechanisms of epigenetic regulation, including DNA methylation, chromatin remodeling,
and histone post-translational modifications, are involved in multiple aspects of neuronal …

Epigenome editing technologies for discovery and medicine

SR McCutcheon, D Rohm, N Iglesias… - Nature …, 2024 - nature.com
Epigenome editing has rapidly evolved in recent years, with diverse applications that
include elucidating gene regulation mechanisms, annotating coding and noncoding …

Time-resolved analysis reveals rapid dynamics and broad scope of the CBP/p300 acetylome

BT Weinert, T Narita, S Satpathy, B Srinivasan… - Cell, 2018 - cell.com
The acetyltransferases CBP and p300 are multifunctional transcriptional co-activators. Here,
we combined quantitative proteomics with CBP/p300-specific catalytic inhibitors …

Rewiring cancer drivers to activate apoptosis

S Gourisankar, A Krokhotin, W Ji, X Liu, CY Chang… - Nature, 2023 - nature.com
Genes that drive the proliferation, survival, invasion and metastasis of malignant cells have
been identified for many human cancers,,–. Independent studies have identified cell death …

Proximity-inducing modalities: the past, present, and future

S Singh, W Tian, ZC Severance… - Chemical Society …, 2023 - pubs.rsc.org
Living systems use proximity to regulate biochemical processes. Inspired by this
phenomenon, bifunctional modalities that induce proximity have been developed to redirect …

Unifying principles of bifunctional, proximity-inducing small molecules

CJ Gerry, SL Schreiber - Nature chemical biology, 2020 - nature.com
Nature uses a variety of tools to mediate the flow of information in cells, many of which
control distances between key biomacromolecules. Researchers have thus generated …

[HTML][HTML] The myotonic dystrophy type 1 drug development pipeline: 2022 edition

M Pascual-Gilabert, R Artero, A López-Castel - Drug discovery today, 2023 - Elsevier
Highlights•Twenty candidate drugs are in current preclinical and clinical phases in
DM1.•Three new interventional first-in-human clinical trials got underway during 2021 …

Recurrent repeat expansions in human cancer genomes

GS Erwin, G Gürsoy, R Al-Abri, A Suriyaprakash… - Nature, 2023 - nature.com
Expansion of a single repetitive DNA sequence, termed a tandem repeat (TR), is known to
cause more than 50 diseases,. However, repeat expansions are often not explored beyond …

Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation

WJ Gibson, A Sadagopan, VM Shoba… - Journal of the …, 2023 - ACS Publications
The aberrant localization of proteins in cells is a key factor in the development of various
diseases, including cancer and neurodegenerative disease. To better understand and …

[HTML][HTML] Friedreich ataxia-pathogenesis and implications for therapies

MB Delatycki, SI Bidichandani - Neurobiology of disease, 2019 - Elsevier
Friedreich ataxia is the most common of the hereditary ataxias. It is due to homozygous/
compound heterozygous mutations in FXN. This gene encodes frataxin, a protein largely …